Michael A. Metzger, CEO: Syndax Pharmaceuticals SNDX Planned sale · Filed 02/06

Trade details

Type: Planned sale notice
Stock: Syndax Pharmaceuticals SNDX
Person: Michael A. MetzgerCEO
Planned sale date: 26/02/06
Filed: 26/02/06

$152.8K to be sold

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/07~03/08

Michael A. Metzger's recent trades

Michael A. MetzgerCEO
Planned sale10b5-1 planSyndax Pharmaceuticals
Planned sale10b5-1 plan
Syndax Pharmaceuticals
SNDX
$752.4K
32,375 sh
$752.4K
Filed 07/08
Traded 07/08
Michael A. MetzgerCEO
SellSyndax Pharmaceuticals
Sell
Syndax Pharmaceuticals
SNDX
$130K
6,847 sh
$130K
Filed 06/02
Traded 06/01
Michael A. MetzgerCEO
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$130K
6,847 sh
$130K
Filed 06/01
Traded 06/01
Michael A. MetzgerCEO
SellSyndax Pharmaceuticals
Sell
Syndax Pharmaceuticals
SNDX
$360.9K
17,159 sh
$360.9K
Filed 02/10
Traded 02/09
Michael A. MetzgerCEO
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$360.8K
17,159 sh
$360.8K
Filed 02/09
Traded 02/09

Michael A. Metzger, CEO — plans to sell 7,412 sh of Syndax Pharmaceuticals SNDX · $152.8K · around 02/06 | Whalegun